Advertisement

Topics

Corticosteroids at Time of PD-L1 Blockade May Reduce Efficacy in NSCLC

06:25 EDT 15 Sep 2018 | Cancer Networks

Taking corticosteroids at the time of treatment initiation with PD-L1 inhibitors may lead to inferior outcomes in patients with non–small-cell lung cancer.

Original Article: Corticosteroids at Time of PD-L1 Blockade May Reduce Efficacy in NSCLC

NEXT ARTICLE

More From BioPortfolio on "Corticosteroids at Time of PD-L1 Blockade May Reduce Efficacy in NSCLC"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...